Bristol-Myers Squibb | BMY - Laba Kotor Pada Penjualan

Harga Saham
57.65
Perubahan Harian
-0.61 -1.05%
Bulanan
-3.48%
Tahunan
14.84%
Q2 Perkiraan
57.45




Laba Kotor Pada Penjualan Perubahan Tanggal
AbbVie USD 12.07B 1.59B 2025-12
Abbott USD 5.86B 675M 2026-03
ALKERMES USD 338.34M 72.51M 2025-12
Amgen USD 6.48B 307M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
Biogen USD 1.65B 34.6M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Coherus Biosciences USD 8.7M 853K 2025-12
Drreddys Laboratories INR 46.81B 10.24B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
J&J USD 17.24B 642M 2026-03
Medtronic USD 5.41B 27M 2025-12
Merck USD 13.42B 431M 2025-09
Novartis USD 10.25B 570M 2025-12
Novo Nordisk DKK 64.01B 1.19B 2025-06
Perrigo USD 362.2M 14.9M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Sanofi EUR 8.45B 3.02B 2025-12
United Therapeutics USD 315.5M 286.6M 2025-12
Zoetis USD 1.64B 73M 2025-12